Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells

被引:3
|
作者
Matsushita, Yuichiro [1 ]
Ohya, Susumu [1 ]
Itoda, Haruna [1 ]
Kimura, Takuya [1 ]
Suzuki, Yoshiaki [1 ]
Yamamura, Hisao [1 ]
Imaizumi, Yuji [1 ]
机构
[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, Nagoya, Aichi 4678603, Japan
基金
日本学术振兴会;
关键词
Kv1.3; channel; T lymphocyte; Jurkat T cell; CD45; CD3; CD28; tyrosine kinase; protein tyrosine phosphatase; p56lck;
D O I
10.1016/j.bbrc.2008.06.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In T lymphocyte, activation of Kv1.3 channel, the major voltage-dependent K+ channel, is an essential step for cell proliferation in immune responses. Here, effects of anti-CD3 and anti-CD28 antibodies on Kv1.3 current were examined in three types of human T lymphocyte derived cell lines, Jurkat E6-1, p56lck-kinase deficient mutant JCaM.1, and CD45-phosphatase deficient mutant J45.01, Kv1.3 current was partly reduced by CD3 Stimulation and more strongly by addition of anti-CD28 antibody in E6-1. In JCaM.1, Kv1.3 current responses to anti-CD28/CD3 antibodies were similar to those in E6-1. In J45.01, CD3 stimulation Partly inhibited Kv1.3 current, but the additive reduction by CD28 stimulation was not significant. The inhibition of tyrosine phosphatase in E6-1 abolished the additional inhibition by anti-CD28 antibody in a similar manner as in J45.01. In conclusion, the stimulation of CD28 in addition to CD3 strongly inhibits Kv1.3 current and this additive inhibition is mediated by CD45 activation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [41] Human regulatory T cell lines maintained with CD3/CD28 T cell expander beads
    Domdey, A
    Liu, A
    Millner, A
    Sondergaard, I
    Würtzen, PA
    IMMUNOLOGY 2004: GENOMIC ISSUES, IMMUNE SYSTEM ACTIVATION AND ALLERGY, 2004, : 163 - 166
  • [42] Comparison of CTS™ Dynabeads® CD3/CD28, Miltenyi TransAct CD3/28 and ExpAct Beads for large-scale CAR T cell manufacturing
    Wang, X.
    Stefanski, J.
    Borquez-Ojeda, O.
    Qu, J.
    Hack, A.
    He, Q.
    Wasielewska, T.
    Du, F.
    Sadelain, M.
    Riviere, I.
    HUMAN GENE THERAPY, 2015, 26 (10) : A31 - A31
  • [43] TOM1L Is Involved in a Novel Signaling Pathway Important for the IL-2 Production in Jurkat T Cells Stimulated by CD3/CD28 CoLigation
    Elmarghani, Ahmed
    Abuabaid, Hanan
    Kjellen, Peter
    MEDIATORS OF INFLAMMATION, 2009, 2009
  • [44] 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells
    Fu, Xiao-Xing
    Du, Li-Li
    Zhao, Ning
    Dong, Qian
    Liao, Yu-Hua
    Du, Yi-Mei
    JOURNAL OF ETHNOPHARMACOLOGY, 2013, 148 (02) : 647 - 654
  • [45] Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia
    Patten, P
    Devereux, S
    Buggins, A
    JOURNAL OF IMMUNOLOGY, 2005, 174 (11): : 6562 - 6563
  • [46] Effect of CD3/CD28 activator on the cytotoxicity of human ex-vivo expanded γδ T cells against osteosarcoma cells
    Ko, Yunmi
    Lee, Jun Ah
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [47] Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28
    Molinero, LL
    Fuertes, MB
    Rabinovich, GA
    Fainboim, L
    Zwirner, NW
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 71 (05) : 791 - 797
  • [48] T-CELL RECEPTOR/CD3 AND CD28 USE DISTINCT INTRACELLULAR SIGNALING PATHWAYS
    VANLIER, RAW
    BROUWER, M
    DEGROOT, E
    KRAMER, I
    AARDEN, LA
    VERHOEVEN, AJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (07) : 1775 - 1778
  • [49] 抗-CD3/CD28磁珠活化T细胞的实验研究
    郑武燕
    李华
    曹倩
    邓彩云
    郑雅文
    世界最新医学信息文摘, 2019, 19 (12) : 14 - 16+19
  • [50] Induction of abortive and productive proliferation in resting human T lymphocytes via CD3 and CD28
    Müller, Y
    Wolf, H
    Wierenga, E
    Jung, G
    IMMUNOLOGY, 1999, 97 (02) : 280 - 286